DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Fosinopril Sodium is a drug marketed by Actavis Labs Fl Inc, Apotex Inc, Aurobindo Pharma Ltd, Invagen Pharms, Prinston Inc, Ranbaxy Labs Ltd, Teva, Upsher Smith Labs, Watson Labs, Ani Pharms Inc, Aurobindo Pharma, Emcure Pharms Ltd, Mylan, Sandoz, and Sun Pharm Inds Ltd. and is included in twenty NDAs.
The generic ingredient in FOSINOPRIL SODIUM is fosinopril sodium; hydrochlorothiazide. There are six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the fosinopril sodium; hydrochlorothiazide profile page.
A generic version of FOSINOPRIL SODIUM was approved as fosinopril sodium; hydrochlorothiazide by SANDOZ on September 28th, 2005.
Summary for FOSINOPRIL SODIUM
|Finished Product Suppliers / Packagers:||9|
|Raw Ingredient (Bulk) Api Vendors:||96|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for FOSINOPRIL SODIUM|
|DailyMed Link:||FOSINOPRIL SODIUM at DailyMed|
Recent Clinical Trials for FOSINOPRIL SODIUM
Identify potential brand extensions & 505(b)(2) entrants
|Ruijin Hospital||Phase 4|
|The First Affiliated Hospital of Zhengzhou University||Phase 4|
|Shanghai Changzheng Hospital||Phase 4|